Sunita Pudasaini
Nurse Practitioner · Rochester Hills, MINPI 1902255532
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 414 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Johnson & Johnson at 25.8% of the total. 2025 is the largest year on record at $3,891, 3.0 times the $1,319 reported in 2023. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 414 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Amgen$1K
- AbbVie$921
- UCB, Inc.$727
- Novartis$560
- AstraZeneca$473
- plus $3K from 22 others
What the payments were for
- Food & beverage$8,39098%
- Education$2022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 102 | $2,218 |
| Amgen(2 entities) | 55 | $1,093 |
| AbbVie | 40 | $921 |
| UCB, Inc. | 29 | $727 |
| Novartis | 24 | $560 |
| AstraZeneca(2 entities) | 17 | $473 |
| Pfizer | 22 | $381 |
| E.r. Squibb & Sons, L.L.C. | 43 | $367 |
| Sanofi | 16 | $251 |
| ANI Pharmaceuticals, Inc. | 10 | $225 |
| Actelion Pharmaceuticals US, Inc. | 4 | $182 |
| Genentech USA, Inc. | 7 | $178 |
| Lilly USA, LLC | 7 | $167 |
| GSK | 8 | $142 |
| Sobi, Inc | 5 | $123 |
| Aurinia Pharma U.S., Inc. | 4 | $100 |
| Mallinckrodt Hospital Products Inc. | 4 | $96 |
| Radius Health, Inc. | 4 | $88 |
| Hospira, Inc. | 2 | $56 |
| Fidia Pharma USA Inc. | 2 | $43 |
| Sandoz | 1 | $30 |
| Invivyd Inc | 2 | $29 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Octapharma USA, Inc. | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| United Therapeutics Corporation | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Organon | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIMPONI ARIA$396
- Tremfya$363
How this compares
$8,592 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 11 | $79,386 |
| Hydroxychloroquine Sulfate | 73 | $3,829 |
| Prednisone | 94 | $837 |
| MethotrexateMethotrexate Sodium | 28 | $748 |
| Duloxetine Hcl | 33 | $684 |
| Colchicine | 12 | $417 |
| Celecoxib | 16 | $269 |
| Tramadol Hcl | 39 | $229 |
| Methylprednisolone | 19 | $223 |
| Gabapentin | 21 | $204 |
| Leflunomide | 13 | $197 |
| Meloxicam | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Rochester Hills
- Davida KrugerDetroit$739K
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
- Debra DegraffGrand Rapids$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.